Connor, Clark & Lunn Investment Management Ltd. - TREACE MED CONCEPTS INC ownership

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 125 filers reported holding TREACE MED CONCEPTS INC in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of TREACE MED CONCEPTS INC
ValueSharesWeighting
Q3 2023$1,192,590
-8.4%
90,968
+78.6%
0.01%
-14.3%
Q2 2023$1,302,534
+60.0%
50,920
+57.6%
0.01%
+75.0%
Q1 2023$813,990
+50.5%
32,314
+37.3%
0.00%
+33.3%
Q4 2022$541,00123,5320.00%
Other shareholders
TREACE MED CONCEPTS INC shareholders Q1 2023
NameSharesValueWeighting ↓
NEXT CENTURY GROWTH INVESTORS LLC 1,537,271$38,723,8564.26%
Millrace Asset Group, Inc. 72,595$1,8292.13%
Divisadero Street Capital Management, LP 175,000$4,408,2501.93%
Perceptive Advisors 2,442,250$61,520,2781.82%
SECTORAL ASSET MANAGEMENT INC 366,443$9,230,6991.77%
EMERALD MUTUAL FUND ADVISERS TRUST 1,120,875$28,234,8411.67%
EMERALD ADVISERS, LLC 1,363,453$34,345,3811.65%
FORMULA GROWTH LTD 124,900$3,146,2311.01%
Novo Holdings A/S 540,000$13,602,6000.90%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 755,379$19,027,9970.78%
View complete list of TREACE MED CONCEPTS INC shareholders